Biolife Solutions (BLFS) Change in Accured Expenses (2010 - 2026)

Biolife Solutions (BLFS) has 17 years of Change in Accured Expenses data on file, last reported at -$4.4 million in Q1 2026.

• Change in Accured Expenses for Q1 2026 came in at -$4.4 million, down 27600.0% year-over-year; the trailing twelve-month figure through Mar 2026 was -$4.2 million (down 144.52% YoY), and the FY2025 annual result was $264000.0, down 95.93% from the prior year.
• Change in Accured Expenses fell to -$4.4 million in Q1 2026 per BLFS's latest filing, from $2.1 million in the prior quarter.
• Over five years, Change in Accured Expenses peaked at $6.8 million in Q4 2024 and troughed at -$4.4 million in Q1 2026.
• A 5-year average of $255687.5 and a median of $7500.0 in 2024 frame the typical range for Change in Accured Expenses.
• The sharpest annual moves came in 2024 and 2025: Change in Accured Expenses surged 1080.84% in 2024, then plunged 182300.0% in 2025.
• A 5-year view of Change in Accured Expenses shows it stood at -$260000.0 in 2022, then jumped by 820.77% to $1.9 million in 2023, then soared by 260.25% to $6.8 million in 2024, then sank by 69.07% to $2.1 million in 2025, then plunged by 310.73% to -$4.4 million in 2026.
• Business Quant data shows BLFS's Change in Accured Expenses at -$4.4 million in Q1 2026, $2.1 million in Q4 2025, and -$1.8 million in Q3 2025.